Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1963 3
1964 1
1965 1
1966 3
1967 2
1968 2
1969 1
1970 2
1971 2
1972 2
1973 2
1974 1
1975 4
1976 1
1977 2
1978 4
1979 5
1980 3
1981 3
1982 9
1983 11
1984 15
1985 16
1986 11
1987 2
1988 6
1989 11
1990 13
1991 14
1992 35
1993 16
1994 22
1995 21
1996 15
1997 12
1998 22
1999 33
2000 24
2001 23
2002 29
2003 20
2004 35
2005 37
2006 28
2007 39
2008 39
2009 39
2010 49
2011 49
2012 56
2013 52
2014 50
2015 68
2016 57
2017 50
2018 50
2019 48
2020 53
2021 65
2022 59
2023 57
2024 62
2025 51
2026 35
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,413 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kaminaga k[Author] (31 results)?
Evidence-based clinical practice guidelines for functional dyspepsia 2021.
Miwa H, Nagahara A, Asakawa A, Arai M, Oshima T, Kasugai K, Kamada K, Suzuki H, Tanaka F, Tominaga K, Futagami S, Hojo M, Mihara H, Higuchi K, Kusano M, Arisawa T, Kato M, Joh T, Mochida S, Enomoto N, Shimosegawa T, Koike K. Miwa H, et al. Among authors: tominaga k. J Gastroenterol. 2022 Feb;57(2):47-61. doi: 10.1007/s00535-021-01843-7. Epub 2022 Jan 21. J Gastroenterol. 2022. PMID: 35061057 Free PMC article. Review.
Hereditary Diffuse Gastric Cancer Treated by Prophylactic Total Gastrectomy.
Inaba Y, Goda K, Kondo M, Abe K, Kanamori A, Suzuki T, Tominaga K, Nakagawa M, Morita S, Kojima K, Ishida K, Irisawa A. Inaba Y, et al. Among authors: tominaga k. Intern Med. 2024 Jan 15;63(2):235-239. doi: 10.2169/internalmedicine.1257-22. Epub 2023 May 24. Intern Med. 2024. PMID: 37225495 Free PMC article.
Development of functional resident macrophages in human pluripotent stem cell-derived colonic organoids and human fetal colon.
Múnera JO, Kechele DO, Bouffi C, Qu N, Jing R, Maity P, Enriquez JR, Han L, Campbell I, Mahe MM, McCauley HA, Zhang X, Sundaram N, Hudson JR, Zarsozo-Lacoste A, Pradhan S, Tominaga K, Sanchez JG, Weiss AA, Chatuvedi P, Spence JR, Hachimi M, North T, Daley GQ, Mayhew CN, Hu YC, Takebe T, Helmrath MA, Wells JM. Múnera JO, et al. Among authors: tominaga k. Cell Stem Cell. 2023 Nov 2;30(11):1434-1451.e9. doi: 10.1016/j.stem.2023.10.002. Cell Stem Cell. 2023. PMID: 37922878 Free PMC article.
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T, Yamazaki H, Miyatani Y, Sawada T, Shibuya N, Fukuo Y, Kiyohara H, Morikubo H, Tominaga K, Kakimoto K, Imai T, Yaguchi K, Yamamoto S, Ando K, Nishimata N, Yoshihara T, Andoh A, Hibi T, Matsuoka K; IBD Terakoya Group. Fukuda T, et al. Among authors: tominaga k. Aliment Pharmacol Ther. 2024 Jul;60(1):43-51. doi: 10.1111/apt.18013. Epub 2024 Apr 23. Aliment Pharmacol Ther. 2024. PMID: 38651779
Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study.
Makuuchi M, Kakuta Y, Umeno J, Fujii T, Takagawa T, Ibuka T, Miura M, Sasaki Y, Takahashi S, Nakase H, Kiyohara H, Tominaga K, Shimodaira Y, Hiraoka S, Ueno N, Yanai S, Yoshihara T, Kakimoto K, Matsuoka K, Hayashi R, Nanjo S, Iwama I, Ishiguro Y, Chiba H, Endo K, Kagaya T, Fukuda T, Sakata Y, Kudo T, Takagi T, Takahashi K, Naganuma M, Shinozaki M, Ogata N, Tanaka H, Narimatsu K, Miyazaki H, Ishige T, Onodera M, Hashimoto Y, Nagai H, Shimoyama Y, Naito T, Moroi R, Shiga H; Post-MENDEL study group; Kinouchi Y, Andoh A, Hisamatsu T, Masamune A. Makuuchi M, et al. Among authors: tominaga k. J Gastroenterol. 2024 Jun;59(6):468-482. doi: 10.1007/s00535-024-02099-7. Epub 2024 Apr 8. J Gastroenterol. 2024. PMID: 38589597 Free PMC article.
Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study.
Kobayashi T, Hisamatsu T, Motoya S, Fujii T, Kunisaki R, Shibuya T, Matsuura M, Takeuchi K, Hiraoka S, Yasuda H, Yokoyama K, Takatsu N, Maemoto A, Tahara T, Tominaga K, Shimada M, Kuno N, Fernandez JL, Ishiguro K, Cavaliere M, Deguchi H, Hibi T. Kobayashi T, et al. Among authors: tominaga k. Intest Res. 2026 Jan;24(1):64-75. doi: 10.5217/ir.2024.00063. Epub 2025 Jan 16. Intest Res. 2026. PMID: 39818201 Free PMC article.
Integrin Inhibitors for Ulcerative Colitis Treatment.
Tanaka T, Tominaga K, Kojimahara S, Kanazawa M, Yamamiya A, Sugaya T, Irisawa A. Tanaka T, et al. Among authors: tominaga k. Digestion. 2025 Dec 11:1-10. doi: 10.1159/000550032. Online ahead of print. Digestion. 2025. PMID: 41379729 Review.
Endoscopic ultrasound-guided vascular interventions.
Irisawa A, Nagashima K, Yamamiya A, Abe Y, Maki T, Kashima K, Kunogi Y, Fukushi K, Sakuma F, Inaba Y, Tominaga K. Irisawa A, et al. Among authors: tominaga k. Dig Endosc. 2025 Jan;37(1):85-92. doi: 10.1111/den.14925. Epub 2024 Sep 25. Dig Endosc. 2025. PMID: 39319363 Review.
The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective study.
Kobayashi T, Hisamatsu T, Motoya S, Matsuura M, Fujii T, Kunisaki R, Shibuya T, Takeuchi K, Hiraoka S, Yasuda H, Yokoyama K, Takatsu N, Maemoto A, Tahara T, Tominaga K, Shimada M, Kuno N, Cavaliere M, Ishiguro K, Fernandez JL, Hibi T. Kobayashi T, et al. Among authors: tominaga k. Intest Res. 2026 Apr;24(2):281-292. doi: 10.5217/ir.2024.00126. Epub 2025 Jun 4. Intest Res. 2026. PMID: 40462299 Free PMC article.
1,413 results